Integrated 5-hydroxymethylcytosine and fragmentation signatures as enhanced biomarkers in lung cancer
24 January 2022 at 08:00
Lung cancer is one of most common cancers worldwide, with a 5-year survival rate of less than 20%, which is mainly due to late-stage diagnosis. Noninvasive methods using 5-hydroxymethylation of cytosine (5hmC)...